Back to Trades
Total Value
$0
Filing Date
Jul 10, 2026
1 transaction
Trade Summary
On Jul 10, 2026, Martin Patricia A., Insider, reported $0 of AN2 Therapeutics, Inc. (ANTX) across 1 transaction. The filing covers Common Stock and reflects balanced net activity of $0. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- AN2 Therapeutics, Inc.
- Ticker Symbol
- ANTX
- CIK
- 0001880438
Insider Information
- Role
- Insider
- Location
- MENLO PARK, CA
Filing Details
- Filing Date
- Jul 10, 2026
- Transaction Date
- Jul 10, 2026
- Accession Number
- 0001193125-26-301165
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 10, 2026 | Common Stock | 766 | — | Grant/Award | — |
Want live alerts when Martin Patricia A. trades again?
Download Insider Trades to track ANTX, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Represents shares issued in lieu of cash compensation under the issuer's non-employee director compensation policy. All shares vest immediately.